Tags : Eli Lilly and Company


MiNA Therapeutics secures £10.83 million Series A Follow On investment

LONDON, United Kingdom, 6 July 2021 — MiNA Therapeutics Limited (“MiNA” or the “Company”), the pioneer in small activating RNA therapeutics, announces that Eli Lilly and Company has entered into a definitive agreement under which it will make a direct equity investment in MiNA. The equity investment of approximately $15m follows the recent agreement between […]Read More